½ÃÀ庸°í¼­
»óǰÄÚµå
1334637

¼¼°èÀÇ ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð Á¶»ç ¹× ¿¹Ãø : ´Ü°èº°, Á¦Ç°º°, ÃÖÁ¾ ¿ëµµº° ¹× Áö¿ªº° ºÐ¼®(2023-2030³â)

Global Brain PET-MRI Systems Market Size study & Forecast, by Phase, by Product, by End-Use, and Regional Analysis, 2023-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Bizwit Research & Consulting LLP | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀåÀº 2022³â ¾à 3¾ï 2,630¸¸ ´Þ·¯·Î Æò°¡µÇ¸ç, ¿¹Ãø ±â°£ÀÎ 2023-2030³â¿¡´Â 5.1% ÀÌ»óÀÇ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

³ú PET-MRI ½Ã½ºÅÛÀº ¾çÀüÀÚ¹æÃâ´ÜÃþÃÔ¿µ(PET)ÀÇ ±â´ÉÀû, ºÐÀÚÀû ¿µ»ó ±â´É°ú ÀÚ±â°ø¸í¿µ»ó(MRI)ÀÌ Á¦°øÇÏ´Â »ó¼¼ÇÑ ÇØºÎÇÐÀû ¿µ»óÀ» °áÇÕÇÑ Ã·´Ü ÀÇ·á¿ë ¿µ»ó ÀåºñÀÔ´Ï´Ù. ÀÌ ½Ã½ºÅÛÀº ³úÀÇ °íÇØ»óµµ À̹ÌÁö¸¦ ÃÔ¿µÇϱâ À§ÇØ Æ¯º°È÷ ¼³°èµÇ¾î ³úÀÇ ±¸Á¶, ±â´É ¹× ´ë»ç Ȱµ¿¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ³ú PET-MRI ½Ã½ºÅÛÀº ½Å°æÇÐ, Á¤½ÅÀÇÇÐ, ½Å°æÁ¾¾çÇÐ µî ´Ù¾çÇÑ ºÐ¾ß¿¡ ±¤¹üÀ§ÇÏ°Ô Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ³ú PET-MRI ½Ã½ºÅÛÀÇ È°¿ëÀº ÇÑ ¹øÀÇ ½ºÄµÀ¸·Î ±â´ÉÀû, ÇØºÎÇÐÀû, ºÐÀÚÀû Á¤º¸¸¦ °áÇÕÇÏ¿© ³ú ¿µ»ó¿¡ ´ëÇÑ ÀüüÀûÀÎ Á¢±Ù ¹æ½ÄÀ» Á¦°øÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ¿µ»ó ±â¼úÀÇ ¹ßÀü, ½Å°æ ÁúȯÀÇ À¯º´·ü Áõ°¡, Á¤¹Ð ÀÇ·áÀÇ Á߿伺 Áõ°¡ µîÀÔ´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é °£Áú, ¾ËÃ÷ÇÏÀ̸Ӻ´, ³úÁ¹Áß, ³úÁ¹Áß, µÎÅë, ³ú¼Õ»ó, ½Å°æ °¨¿°, ´Ù¹ß¼º °æÈ­Áõ, ÆÄŲ½¼º´ µî ´Ù¾çÇÑ ½Å°æÁúȯÀ» ¾Î°í ÀÖ´Â »ç¶÷ÀÌ Àü ¼¼°èÀûÀ¸·Î 10¾ï ¸í¿¡ ´ÞÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Å°æ ÁúȯÀÇ Áõ°¡´Â ½É°¢ÇÑ µµÀüÀ» Á¦±âÇϰí ÀÖÀ¸¸ç, Àü ¼¼°èÀûÀ¸·Î °³ÀÎ, °¡Á· ¹× ÀÇ·á ½Ã½ºÅÛ¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¼¼°è Á¤¹ÐÀÇ·á ½ÃÀåµµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, Statista¿¡ µû¸£¸é 2026³â±îÁö ½Å°æÁúȯ ¼¼°è ½ÃÀåÀº 1,400¾ï ´Þ·¯ ÀÌ»ó¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¶ÇÇÑ AI(ÀΰøÁö´É)¿Í ML(¸Ó½Å·¯´×) ±â¼úÀÇ ÅëÇÕÀº ½ÃÀå ¼ºÀå¿¡ À¯¸®ÇÑ ±âȸ¸¦ âÃâÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª PET-MRI ½Ã½ºÅÛÀÇ ³ôÀº ºñ¿ë°ú ÁÖ¿ä ÀÇ·á ±â°ü ¹× ¿¬±¸ ¼¾ÅÍ¿¡¼­ÀÇ Á¦ÇÑµÈ »ç¿ëÀº 2023-2030³â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå Á¶»ç¿¡¼­ °í·ÁµÈ ÁÖ¿ä Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾ç, ºÏ¹Ì, À¯·´, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« µîÀÔ´Ï´Ù. ºÏ¹Ì´Â ÀÌ Áö¿ªÀÇ ½Å°æ Áúȯ À¯º´·ü Áõ°¡·Î ÀÎÇØ 2022³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÏ¸ç ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù. ¹Ì±¹½Å°æÇÐȸ´Â ¹Ì±¹¿¡¼­ °¡Àå ÈçÇÏ°Ô °üÂûµÇ´Â ½Å°æ Áúȯ¿¡´Â ¾ËÃ÷ÇÏÀ̸Ӻ´, ³úÁ¹Áß, ¿Ü»ó¼º ³ú¼Õ»ó, °£Áú, ´Ù¹ß¼º °æÈ­Áõ, ÆÄŲ½¼º´ÀÌ Æ÷ÇÔµÈ´Ù°í º¸°íÇß½À´Ï´Ù. ±×·¯³ª ¾Æ½Ã¾ÆÅÂÆò¾çÀÌ ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸£°Ô ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â ¿¬±¸ ¼¾ÅÍ¿Í ´ëÇп¡¼­ ÷´Ü Áø´Ü ÀåºñÀÇ »ç¿ëÀÌ Áõ°¡Çϸ鼭 ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. Àεµ, ÀϺ», Áß±¹ µîÀÇ ±¹°¡¿¡¼­ Áø´Ü ½Ã½ºÅÛ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ÇâÈÄ ¸î ³â µ¿¾È ÀÌ Áö¿ª ½ÃÀåÀÇ ÁÖ¿ä ÃËÁøÁ¦°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ Á¶»çÀÇ ¸ñÀûÀº ÃÖ±Ù ¸î ³â°£ ´Ù¾çÇÑ ºÎ¹®°ú ±¹°¡ÀÇ ½ÃÀå ±Ô¸ð¸¦ ÆÄ¾ÇÇϰí ÇâÈÄ ¸î ³â°£ ½ÃÀå ±Ô¸ð¸¦ ¿¹ÃøÇÏ´Â °ÍÀÔ´Ï´Ù. ÀÌ º¸°í¼­´Â Á¶»ç ´ë»ó ±¹°¡ÀÇ »ê¾÷ÀÇ ÁúÀû, ¾çÀû Ãø¸éÀ» ¸ðµÎ Æ÷ÇÔÇϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù.

¶ÇÇÑ ½ÃÀåÀÇ ¹Ì·¡ ¼ºÀåÀ» ±ÔÁ¤ÇÏ´Â ÃËÁø¿äÀΰú °úÁ¦¿Í °°Àº Áß¿äÇÑ Ãø¸é¿¡ ´ëÇÑ ÀÚ¼¼ÇÑ Á¤º¸µµ Á¦°øÇÕ´Ï´Ù. ¶ÇÇÑ, ÁÖ¿ä ±â¾÷ÀÇ °æÀï »óȲ°ú Á¦Ç° Á¦°ø¿¡ ´ëÇÑ »ó¼¼ÇÑ ºÐ¼®°ú ÇÔ²² ÀÌÇØ°ü°èÀÚ°¡ ÅõÀÚÇÒ ¼ö ÀÖ´Â ¸¶ÀÌÅ©·Î ½ÃÀåÀÇ ÀáÀçÀû ±âȸµµ Æ÷ÇԵ˴ϴÙ.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼¼°èÀÇ ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§

  • Á¶»ç ¸ñÀû
  • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
    • »ê¾÷ÀÇ ÁøÈ­
    • Á¶»ç ¹üÀ§
  • Á¶»ç ´ë»ó ¿¬µµ
  • ÅëÈ­ ȯ»êÀ²

Á¦3Àå ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå ¿ªÇÐ

  • ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀåÀÇ ¿µÇ⠺м®(2020-2030³â)
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
      • À̹Ì¡ ±â¼ú Áøº¸
      • ½Å°æÁúȯ Áõ°¡
      • Á¤¹ÐÀÇ·áÀÇ Á߿伺 »ó½Â
    • ½ÃÀå °úÁ¦
      • PET-MRI ½Ã½ºÅÛÀÇ °íºñ¿ë
      • ÁÖ¿ä ÇコÄÉ¾î ±â°üÀ̳ª ¿¬±¸ ¼¾ÅÍ¿¡¼­ÀÇ ÀÌ¿ëÀÌ ÇÑÁ¤Àû
    • ½ÃÀå ±âȸ
      • AI¿Í ML±â¼ú ÅëÇÕ

Á¦4Àå ¼¼°èÀÇ ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå »ê¾÷ ºÐ¼®

  • Porter's 5 Force ¸ðµ¨
    • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
    • ±¸¸ÅÀÚÀÇ ±³¼··Â
    • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
    • ´ëüǰÀÇ À§Çù
    • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è
  • Porter's 5 Force ¿µÇ⠺м®
  • PEST ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ȯ°æ
    • ¹ý·ü
  • ÁÖ¿ä ÅõÀÚ ±âȸ
  • ÁÖ¿ä ¼º°ø Àü·«
  • COVID-19 ¿µÇ⠺м®
  • ÆÄ±«Àû µ¿Çâ
  • ¾÷°è Àü¹®°¡ÀÇ °üÁ¡
  • ¾Ö³Î¸®½ºÆ®ÀÇ °á·Ð°ú Á¦¾È

Á¦5Àå ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ´Ü°èº°

  • ½ÃÀå ÇöȲ
  • ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ´Ü°èº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ´Ü°èº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ÀÓ»ó
    • ÀüÀÓ»ó

Á¦6Àå ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : Á¦Ç°º°

  • ½ÃÀå ÇöȲ
  • ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : Á¦Ç°º°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : Á¦Ç°º° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • ±âÁ¸ PET-MRI ½Ã½ºÅÛ
    • Çï·ý ÇÁ¸® PET-MRI ½Ã½ºÅÛ

Á¦7Àå ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

  • ½ÃÀå ÇöȲ
  • ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº°, ½ÇÀû - ÀáÀ缺 ºÐ¼®
  • ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
  • ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå, ÇÏÀ§ ºÎ¹® ºÐ¼®
    • º´¿ø
    • ¿µ»ó Áø´Ü ¼¾ÅÍ
    • ±âŸ

Á¦8Àå ³ú PET-MRI ½Ã½ºÅÛ ¼¼°è ½ÃÀå : Áö¿ªº° ºÐ¼®

  • ÁÖ¿ä ±¹°¡
  • ÁÖ¿ä ½ÅÈï ±¹°¡
  • ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå, Áö¿ªº° ½ÃÀå ÇöȲ
  • ºÏ¹Ì
    • ¹Ì±¹
      • ´Ü°è ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • Á¦Ç° ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
      • ÃÖÁ¾ ¿ëµµ ÃßÁ¤¡¤¿¹Ãø, 2020-2030³â
    • ij³ª´Ù
  • À¯·´³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå ÇöȲ
    • ¿µ±¹
    • µ¶ÀÏ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ÀÌÅ»¸®¾Æ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå ÇöȲ
    • Áß±¹
    • Àεµ
    • ÀϺ»
    • È£ÁÖ
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ ³ú PET-MRI ½Ã½ºÅÛ ½ÃÀå ÇöȲ
    • ºê¶óÁú
    • ¸ß½ÃÄÚ
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï Á¤º¸

  • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®
  • ÁÖ¿ä ½ÃÀå Àü·«
  • ±â¾÷ °³¿ä
    • Siemens Healthineers AG
      • ÁÖ¿ä Á¤º¸
      • °³¿ä
      • À繫(µ¥ÀÌÅÍ °¡¿ë¼º¿¡ µû¶ó ´Ù¸§)
      • Á¦Ç° °³¿ä
      • ÃÖ±ÙÀÇ µ¿Çâ
    • Cubresa Inc.
    • Aspect Imaging Ltd.
    • Mediso Ltd.
    • Koninklijke Philips N.V.
    • Canon Medical Systems Corporation
    • Quality Electrodynamics
    • Shenzhen Mindray Bio-Medical Electronics Co.
    • GE Healthcare
    • MR Solutions

Á¦10Àå Á¶»ç °úÁ¤

  • Á¶»ç °úÁ¤
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • ºÐ¼®
    • ½ÃÀå ÃßÁ¤
    • °ËÁõ
    • ÃâÆÇ
  • Á¶»ç ¼Ó¼º
  • Á¶»ç °¡Á¤
ksm 23.09.19

Global Brain PET-MRI Systems Market is valued approximately at USD 326.3 Million in 2022 and is anticipated to grow with a growth rate of more than 5.1% over the forecast period 2023-2030. Brain PET-MRI systems are advanced medical imaging devices that combine the functional and molecular imaging capabilities of positron emission tomography (PET) with the detailed anatomical imaging provided by magnetic resonance imaging (MRI). These systems are specifically designed for capturing high-resolution images of the brain, offering comprehensive insights into its structure, function, and metabolic activity. The application of Brain PET-MRI systems is diverse and spans various fields, including neurology, psychiatry, and neuro-oncology. The utilization of Brain PET-MRI systems offers a holistic approach to brain imaging by combining functional, anatomical, and molecular information in a single scan. The driving factors that are boosting the market growth is advancement in imaging technology, rising prevalence of Neurological Disorders, growing importance of Precision Medicine.

According to the World Health Organization (WHO), up to one billion people globally are affected by a wide range of neurological disorders, including epilepsy, Alzheimer's disease, stroke, headaches, brain injuries, neuroinfections, multiple sclerosis, and Parkinson's disease. This increase in neurological disorders poses significant challenges and impacts individuals, families, and healthcare systems globally. The global precision medicine market is also contributing to the market growth. According to Statista, the global market for neurological disorders is projected to reach over 140 billion dollars by 2026. Moreover, integration of AI (Artificial Intelligence) and ML (Machine Learning) technologies is expected to create lucrative opportunities for the market growth. However, the high cost of PET-MRI Systems and limited availability to major healthcare institutions or research centers stifles market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Brain PET-MRI Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 with largest market share due to the growing prevalence of neurological disorders in the region, the American Neurological Association has reported that the most commonly observed neurological disorders in the United States include Alzheimer's disease, stroke, traumatic brain injury, epilepsy, multiple sclerosis, and Parkinson's disease. However, Asia Pacific is expected to be the fastest growing region during the forecast period, owing to a rise in the utilization of advanced diagnostic machines within research centers and universities, fueling the market growth. The increasing demand for diagnostic systems in countries such as India, Japan, and China is expected to be a key driver for the regional market in the coming years.

Major market player included in this report are:

  • Siemens Healthineers AG
  • Cubresa Inc.
  • Aspect Imaging Ltd.
  • Mediso Ltd.
  • Koninklijke Philips N.V.
  • Canon Medical Systems Corporation
  • Quality Electrodynamics
  • Shenzhen Mindray Bio-Medical Electronics Co.
  • GE Healthcare
  • MR Solutions

Recent Developments in the Market:

  • In January 2023, Canon Medical Systems USA Inc., a subsidiary of Canon Medical Systems Corporation, has successfully finalized a strategic partnership agreement with ScImage, Inc. This collaboration brings together Canon's expertise in cutting-edge diagnostic imaging technology and ScImage's capabilities, fostering advancements in the field of medical imaging.
  • In June 2023, Mindray has launched its BeneFusion i Series and u Series infusion systems, designed to provide enhanced precision, adaptive customization, and simplified operation, ensuring a high level of medication safety in diverse clinical settings. The new series will initially be available in specific countries and regions, offering healthcare professionals advanced infusion technology for improved patient care.
  • In April 2023, Siemens Healthineers expanded its manufacturing operations in India with the inauguration of an MRI facility in Bengaluru. This development is in line with the Government of India's PLI (Production-Linked Incentive) scheme. The facility's primary focus will be on manufacturing MAGNETOM Free.Star, a helium-free and user-friendly MRI system that offers high-quality imaging.

Global Brain PET-MRI Systems Market Report Scope:

  • Historical Data: 2020 - 2021
  • Base Year for Estimation: 2022
  • Forecast period: 2023-2030
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Phase, Product, End-Use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Middle East & Africa
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Phase:

  • Clinical
  • Pre-Clinical

By Product:

  • Traditional PET-MRI Systems
  • Helium-Free PET-MRI Systems

By End-Use:

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

By Region:

  • North America
    • U.S.
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Italy
    • ROE
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • RoAPAC
  • Latin America
    • Brazil
    • Mexico
  • Middle East & Africa
    • Saudi Arabia
    • South Africa
    • Rest of Middle East & Africa

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
    • 1.2.1. Brain PET-MRI Systems Market, by region, 2020-2030 (USD Million)
    • 1.2.2. Brain PET-MRI Systems Market, by Phase, 2020-2030 (USD Million)
    • 1.2.3. Brain PET-MRI Systems Market, by Product, 2020-2030 (USD Million)
    • 1.2.4. Brain PET-MRI Systems Market, by End-Use, 2020-2030 (USD Million)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Brain PET-MRI Systems Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Industry Evolution
    • 2.2.2. Scope of the Study
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Brain PET-MRI Systems Market Dynamics

  • 3.1. Brain PET-MRI Systems Market Impact Analysis (2020-2030)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Advancement in Imaging Technology
      • 3.1.1.2. Growing prevalence of Neurological Disorders
      • 3.1.1.3. Growing importance of Precision Medicine
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of PET-MRI Systems
      • 3.1.2.2. Limited availability to major healthcare institutions or research centres
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Integration of AI and ML technologies

Chapter 4. Global Brain PET-MRI Systems Market: Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Porter's 5 Force Impact Analysis
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economic
    • 4.3.3. Social
    • 4.3.4. Technological
    • 4.3.5. Environmental
    • 4.3.6. Legal
  • 4.4. Top investment opportunity
  • 4.5. Top winning strategies
  • 4.6. COVID-19 Impact Analysis
  • 4.7. Disruptive Trends
  • 4.8. Industry Expert Perspective
  • 4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Brain PET-MRI Systems Market, by Phase

  • 5.1. Market Snapshot
  • 5.2. Global Brain PET-MRI Systems Market by Phase, Performance - Potential Analysis
  • 5.3. Global Brain PET-MRI Systems Market Estimates & Forecasts by Phase 2020-2030 (USD Million)
  • 5.4. Brain PET-MRI Systems Market, Sub Segment Analysis
    • 5.4.1. Clinical
    • 5.4.2. Pre-Clinical

Chapter 6. Global Brain PET-MRI Systems Market, by Product

  • 6.1. Market Snapshot
  • 6.2. Global Brain PET-MRI Systems Market by Product, Performance - Potential Analysis
  • 6.3. Global Brain PET-MRI Systems Market Estimates & Forecasts by Product 2020-2030 (USD Million)
  • 6.4. Brain PET-MRI Systems Market, Sub Segment Analysis
    • 6.4.1. Traditional PET-MRI Systems
    • 6.4.2. Helium-Free PET-MRI Systems

Chapter 7. Global Brain PET-MRI Systems Market, by End-Use

  • 7.1. Market Snapshot
  • 7.2. Global Brain PET-MRI Systems Market by End-Use, Performance - Potential Analysis
  • 7.3. Global Brain PET-MRI Systems Market Estimates & Forecasts by End-Use 2020-2030 (USD Million)
  • 7.4. Brain PET-MRI Systems Market, Sub Segment Analysis
    • 7.4.1. Hospitals
    • 7.4.2. Diagnostic Imaging Centers
    • 7.4.3. Others

Chapter 8. Global Brain PET-MRI Systems Market, Regional Analysis

  • 8.1. Top Leading Countries
  • 8.2. Top Emerging Countries
  • 8.3. Brain PET-MRI Systems Market, Regional Market Snapshot
  • 8.4. North America Brain PET-MRI Systems Market
    • 8.4.1. U.S. Brain PET-MRI Systems Market
      • 8.4.1.1. Phase breakdown estimates & forecasts, 2020-2030
      • 8.4.1.2. Product breakdown estimates & forecasts, 2020-2030
      • 8.4.1.3. End-Use breakdown estimates & forecasts, 2020-2030
    • 8.4.2. Canada Brain PET-MRI Systems Market
  • 8.5. Europe Brain PET-MRI Systems Market Snapshot
    • 8.5.1. U.K. Brain PET-MRI Systems Market
    • 8.5.2. Germany Brain PET-MRI Systems Market
    • 8.5.3. France Brain PET-MRI Systems Market
    • 8.5.4. Spain Brain PET-MRI Systems Market
    • 8.5.5. Italy Brain PET-MRI Systems Market
    • 8.5.6. Rest of Europe Brain PET-MRI Systems Market
  • 8.6. Asia-Pacific Brain PET-MRI Systems Market Snapshot
    • 8.6.1. China Brain PET-MRI Systems Market
    • 8.6.2. India Brain PET-MRI Systems Market
    • 8.6.3. Japan Brain PET-MRI Systems Market
    • 8.6.4. Australia Brain PET-MRI Systems Market
    • 8.6.5. South Korea Brain PET-MRI Systems Market
    • 8.6.6. Rest of Asia Pacific Brain PET-MRI Systems Market
  • 8.7. Latin America Brain PET-MRI Systems Market Snapshot
    • 8.7.1. Brazil Brain PET-MRI Systems Market
    • 8.7.2. Mexico Brain PET-MRI Systems Market
  • 8.8. Middle East & Africa Brain PET-MRI Systems Market
    • 8.8.1. Saudi Arabia Brain PET-MRI Systems Market
    • 8.8.2. South Africa Brain PET-MRI Systems Market
    • 8.8.3. Rest of Middle East & Africa Brain PET-MRI Systems Market

Chapter 9. Competitive Intelligence

  • 9.1. Key Company SWOT Analysis
    • 9.1.1. Company 1
    • 9.1.2. Company 2
    • 9.1.3. Company 3
  • 9.2. Top Market Strategies
  • 9.3. Company Profiles
    • 9.3.1. Siemens Healthineers AG
      • 9.3.1.1. Key Information
      • 9.3.1.2. Overview
      • 9.3.1.3. Financial (Subject to Data Availability)
      • 9.3.1.4. Product Summary
      • 9.3.1.5. Recent Developments
    • 9.3.2. Cubresa Inc.
    • 9.3.3. Aspect Imaging Ltd.
    • 9.3.4. Mediso Ltd.
    • 9.3.5. Koninklijke Philips N.V.
    • 9.3.6. Canon Medical Systems Corporation
    • 9.3.7. Quality Electrodynamics
    • 9.3.8. Shenzhen Mindray Bio-Medical Electronics Co.
    • 9.3.9. GE Healthcare
    • 9.3.10. MR Solutions

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦